TCRCure Revenue and Competitors
Estimated Revenue & Valuation
- TCRCure's estimated annual revenue is currently $4M per year.
- TCRCure's estimated revenue per employee is $155,000
Employee Data
- TCRCure has 26 Employees.
- TCRCure grew their employee count by -7% last year.
TCRCure's People
| Name | Title | Email/Phone |
|---|
TCRCure Competitors & AlternativesAdd Company
| Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
|---|---|---|---|---|---|
#1 | $99.4M | 458 | 40% | N/A | N/A |
#2 | $20.6M | 133 | 22% | N/A | N/A |
#3 | $156.1M | 146 | -70% | $145M | N/A |
#4 | $3.5M | 45 | -25% | $150M | N/A |
#5 | $1.6M | 21 | 0% | $459.5M | N/A |
#6 | $67.3M | 310 | 16% | $180.7M | N/A |
#7 | $8.5M | 55 | -2% | N/A | N/A |
#8 | $256.3M | 1025 | 9% | $168.5M | N/A |
#9 | $2.8M | 18 | -33% | N/A | N/A |
#10 | $9.1M | 59 | -9% | N/A | N/A |
What Is TCRCure?
TCRCure Biopharma Ltd. aims to develop next generation cancer immunotherapies that control tumor progression, convert life-threatening cancers to manageable diseases, and eventually lead to cures. We are a leading international company focused on streamlined biotechnology development including high throughput antigen-specific TCR cloning, industry-scale virus production, T cell genetic engineering, and immune cell manufacturing.
keywords:N/A
N/A
Total Funding
26
Number of Employees
$4M
Revenue (est)
-7%
Employee Growth %
N/A
Valuation
N/A
Accelerator
TCRCure News
2022-04-06 - China VC Investment List Q1 2022 Healthcare
TCRCure was established in 2016, focusing on the tumor immune cell therapy technology.. Hugo Biotech. Pathogenic microorganism sequencing...
Other Companies in
| Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
|---|---|---|---|---|
#1 | $2.7M | 26 | -16% | N/A |
#2 | $3.8M | 26 | 30% | N/A |
#3 | $3.5M | 26 | 63% | N/A |
#4 | $2.6M | 26 | N/A | N/A |
#5 | $2.6M | 26 | N/A | N/A |